- IKT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
-
Institutional
- Shorts
Inhibikase Therapeutics (IKT) Institutional ownership
Company Profile
Type | Filer | #Shares | Filed | For date | #Previous | %Chg | Prev. Date |
---|---|---|---|---|---|---|---|
13F-HR/A
|
Jefferies Financial | 14.80 k | 27 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
13F-HR/A
|
Alpine Global Management | 14.84 k | 18 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
SC 13G
|
ADAR1 Capital Management GP | 6.99 mm | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
SC 13G/A
|
Armistice Capital | 3.53 mm | 14 Feb 25 | 31 Dec 24 | 626.50 k | +463% | 30 Sep 24 |
13F-HR
|
Nantahala Capital Management | 2.19 mm | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
SC 13G
|
Nantahala Capital Management | 5.30 mm | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
13F-HR
|
Morgan Stanley | 5.63 k | 14 Feb 25 | 31 Dec 24 | 1.67 k | +238% | 30 Sep 24 |
13F-HR
|
Millennium Management | 142.21 k | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
13F-HR
|
Perceptive Advisors | 5.93 mm | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
SC 13G/A
|
Point72 Asset Management, L.P | 0.00 | 14 Feb 25 | 31 Dec 24 | 0.00 | 30 Sep 24 |
This data is updated daily from 13F, 13D and 13G SEC filings.
Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.